• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

垂体神经内分泌肿瘤的免疫微环境全景:转录组学方法。

The Immune Microenvironment Landscape of Pituitary NeuroEndocrine Tumors, a Transcriptomic Approach.

机构信息

Unidad de Investigación Médica en Enfermedades Endocrinas, Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Av. Cuauhtémoc 330, Col. Doctores, Ciudad de México 06720, Mexico.

Laboratorio Nacional de Vacunología y Virus Tropicales, Departamento de Microbiología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Ciudad de México 11350, Mexico.

出版信息

Genes (Basel). 2024 Apr 24;15(5):531. doi: 10.3390/genes15050531.

DOI:10.3390/genes15050531
PMID:38790160
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11120841/
Abstract

Pituitary neuroendocrine tumors (PitNET) are known to be variably infiltrated by different immune cells. Nonetheless, their role in pituitary oncogenesis has only begun to be unveiled. The immune microenvironment could determine the biological and clinical behavior of a neoplasm and may have prognostic implications. To evaluate the expression of immune-related genes and to correlate such expression with the presence of infiltrating immune cells in forty-two PitNETs of different lineages, we performed whole transcriptome analysis and RT-qPCR. Deconvolution analysis was carried out to infer the immune cell types present in each tumor and the presence of immune cells was confirmed by immunofluorescence. We found characteristic expression profiles of immune-related genes including those encoding interleukins and chemokines for each tumor lineage. Genes such as , , , , and were upregulated in all PitNETS, whereas , , and characterize the , -, and -derived tumors, respectively. Transcriptome deconvolution analysis showed that M2 macrophages, CD4+ T cells, CD8+ T cells, NK cells, and neutrophils can potentially infiltrate PitNET. Furthermore, CD4+ and CD8+ T cells and NK cells infiltration was validated by immunofluorescence. Expression of , and as well as macrophage tumor infiltration could identify patients who can potentially benefit from treatment with immune checkpoint inhibitors.

摘要

垂体神经内分泌肿瘤(PitNET)已知被不同的免疫细胞浸润。尽管如此,它们在垂体肿瘤发生中的作用才刚刚开始被揭示。免疫微环境可以决定肿瘤的生物学和临床行为,并可能具有预后意义。为了评估 42 例不同谱系的 PitNET 中与免疫相关的基因表达,并将这种表达与浸润免疫细胞的存在相关联,我们进行了全转录组分析和 RT-qPCR。去卷积分析用于推断每个肿瘤中存在的免疫细胞类型,并通过免疫荧光确认免疫细胞的存在。我们发现了每个肿瘤谱系中具有特征性的免疫相关基因表达谱,包括编码白细胞介素和趋化因子的基因。、、、和在所有 PitNET 中均上调,而、和分别特征化为、-和-衍生的肿瘤。转录组去卷积分析表明,M2 巨噬细胞、CD4+T 细胞、CD8+T 细胞、NK 细胞和中性粒细胞可能浸润 PitNET。此外,通过免疫荧光验证了 CD4+和 CD8+T 细胞以及 NK 细胞的浸润。表达、和巨噬细胞肿瘤浸润可以识别出可能受益于免疫检查点抑制剂治疗的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2107/11120841/9458a1ce40f6/genes-15-00531-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2107/11120841/06966f7794e2/genes-15-00531-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2107/11120841/1c7b6fa3b176/genes-15-00531-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2107/11120841/10ceb8e90821/genes-15-00531-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2107/11120841/af73093354f9/genes-15-00531-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2107/11120841/a98729dad4f7/genes-15-00531-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2107/11120841/abc6453ce48c/genes-15-00531-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2107/11120841/9458a1ce40f6/genes-15-00531-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2107/11120841/06966f7794e2/genes-15-00531-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2107/11120841/1c7b6fa3b176/genes-15-00531-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2107/11120841/10ceb8e90821/genes-15-00531-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2107/11120841/af73093354f9/genes-15-00531-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2107/11120841/a98729dad4f7/genes-15-00531-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2107/11120841/abc6453ce48c/genes-15-00531-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2107/11120841/9458a1ce40f6/genes-15-00531-g007.jpg

相似文献

1
The Immune Microenvironment Landscape of Pituitary NeuroEndocrine Tumors, a Transcriptomic Approach.垂体神经内分泌肿瘤的免疫微环境全景:转录组学方法。
Genes (Basel). 2024 Apr 24;15(5):531. doi: 10.3390/genes15050531.
2
Single-cell transcriptomics reveal distinct immune-infiltrating phenotypes and macrophage-tumor interaction axes among different lineages of pituitary neuroendocrine tumors.单细胞转录组学揭示了垂体神经内分泌肿瘤不同谱系之间独特的免疫浸润表型和巨噬细胞-肿瘤相互作用轴。
Genome Med. 2024 Apr 24;16(1):60. doi: 10.1186/s13073-024-01325-4.
3
Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours.趋化因子调节垂体神经内分泌肿瘤的肿瘤微环境。
Acta Neuropathol Commun. 2019 Nov 8;7(1):172. doi: 10.1186/s40478-019-0830-3.
4
Tumor immune microenvironment in pituitary neuroendocrine tumors (PitNETs): increased M2 macrophage infiltration and PD-L1 expression in PIT1-lineage subset.垂体神经内分泌肿瘤(PitNETs)中的肿瘤免疫微环境:PIT1 谱系亚群中 M2 巨噬细胞浸润和 PD-L1 表达增加。
J Neurooncol. 2023 Jul;163(3):663-674. doi: 10.1007/s11060-023-04382-8. Epub 2023 Jul 7.
5
The expression of neural cell adhesion molecule and the microenvironment of pituitary neuroendocrine tumours.神经细胞黏附分子的表达与垂体神经内分泌肿瘤的微环境
J Neuroendocrinol. 2021 Dec;33(12):e13052. doi: 10.1111/jne.13052. Epub 2021 Oct 27.
6
Immune Landscape of Pituitary Tumors Reveals Association Between Macrophages and Gonadotroph Tumor Invasion.垂体瘤的免疫景观揭示了巨噬细胞与促性腺细胞瘤侵袭之间的关联。
J Clin Endocrinol Metab. 2020 Nov 1;105(11). doi: 10.1210/clinem/dgaa520.
7
Immune landscape and progress in immunotherapy for pituitary neuroendocrine tumors.垂体神经内分泌肿瘤的免疫景观与免疫治疗进展。
Cancer Lett. 2024 Jun 28;592:216908. doi: 10.1016/j.canlet.2024.216908. Epub 2024 Apr 25.
8
Comprehensive analysis of the immunological landscape of pituitary adenomas: implications of immunotherapy for pituitary adenomas.全面分析垂体腺瘤的免疫图谱:免疫治疗对垂体腺瘤的影响。
J Neurooncol. 2020 Sep;149(3):473-487. doi: 10.1007/s11060-020-03636-z. Epub 2020 Oct 9.
9
From the Immune Profile to the Immunoscore: Signatures for Improving Postsurgical Prognostic Prediction of Pancreatic Neuroendocrine Tumors.从免疫图谱到免疫评分:改善胰腺神经内分泌肿瘤术后预后预测的标志物
Front Immunol. 2021 Apr 23;12:654660. doi: 10.3389/fimmu.2021.654660. eCollection 2021.
10
Single-cell transcriptomic analysis reveals tumor cell heterogeneity and immune microenvironment features of pituitary neuroendocrine tumors.单细胞转录组分析揭示了垂体神经内分泌肿瘤的肿瘤细胞异质性和免疫微环境特征。
Genome Med. 2024 Jan 2;16(1):2. doi: 10.1186/s13073-023-01267-3.

引用本文的文献

1
The Roles of PD-L1, Ki-67, P53, and Cyclin D1 in PitNETs: Diagnostic and Prognostic Implications in a Series of 74 Patients.PD-L1、Ki-67、P53和细胞周期蛋白D1在垂体神经内分泌肿瘤中的作用:74例患者的诊断和预后意义
Int J Mol Sci. 2025 Aug 13;26(16):7830. doi: 10.3390/ijms26167830.
2
IL-36-related genes predict prognosis of gastric cancer.白细胞介素-36相关基因可预测胃癌预后。
Front Oncol. 2025 Jun 18;15:1566993. doi: 10.3389/fonc.2025.1566993. eCollection 2025.
3
New insights in cellular senescence: The pituitary model.细胞衰老的新见解:垂体模型。

本文引用的文献

1
Aggressive PitNETs and Potential Target Therapies: A Systematic Review of Molecular and Genetic Pathways.侵袭性 PitNETs 及潜在的靶向治疗:分子和遗传途径的系统综述。
Int J Mol Sci. 2023 Oct 29;24(21):15719. doi: 10.3390/ijms242115719.
2
PD-L1 Expression in Pituitary Neuroendocrine Tumors/Pituitary Adenomas.垂体神经内分泌肿瘤/垂体腺瘤中的程序性死亡受体配体1(PD-L1)表达
Cancers (Basel). 2023 Sep 8;15(18):4471. doi: 10.3390/cancers15184471.
3
Tumor immune microenvironment in pituitary neuroendocrine tumors (PitNETs): increased M2 macrophage infiltration and PD-L1 expression in PIT1-lineage subset.
J Neuroendocrinol. 2025 May;37(5):e70008. doi: 10.1111/jne.70008. Epub 2025 Mar 3.
垂体神经内分泌肿瘤(PitNETs)中的肿瘤免疫微环境:PIT1 谱系亚群中 M2 巨噬细胞浸润和 PD-L1 表达增加。
J Neurooncol. 2023 Jul;163(3):663-674. doi: 10.1007/s11060-023-04382-8. Epub 2023 Jul 7.
4
Tumour microenvironment and pituitary tumour behaviour.肿瘤微环境与垂体肿瘤行为
J Endocrinol Invest. 2023 Jun;46(6):1047-1063. doi: 10.1007/s40618-023-02089-1. Epub 2023 Apr 15.
5
IL-36 expression is increased in NSCLC with IL-36 stimulation of lung cancer cells promoting a pro-tumorigenic phenotype.在非小细胞肺癌(NSCLC)中,白细胞介素-36(IL-36)的表达增加,IL-36对肺癌细胞的刺激促进了促肿瘤表型。
Cytokine. 2023 May;165:156170. doi: 10.1016/j.cyto.2023.156170. Epub 2023 Mar 15.
6
Integrated proteogenomic characterization across major histological types of pituitary neuroendocrine tumors.整合垂体神经内分泌肿瘤主要组织学类型的蛋白质基因组特征分析。
Cell Res. 2022 Dec;32(12):1047-1067. doi: 10.1038/s41422-022-00736-5. Epub 2022 Oct 28.
7
Immunotherapy for Aggressive and Metastatic Pituitary Neuroendocrine Tumors (PitNETs): State-of-the Art.侵袭性和转移性垂体神经内分泌肿瘤(PitNETs)的免疫治疗:最新进展
Cancers (Basel). 2022 Aug 24;14(17):4093. doi: 10.3390/cancers14174093.
8
Overview of the 2022 WHO Classification of Pituitary Tumors.《2022 年世卫组织垂体肿瘤分类概述》。
Endocr Pathol. 2022 Mar;33(1):6-26. doi: 10.1007/s12022-022-09703-7. Epub 2022 Mar 15.
9
The kinome, cyclins and cyclin-dependent kinases of pituitary adenomas, a look into the gene expression profile among tumors from different lineages.垂体腺瘤的激酶组、细胞周期蛋白和细胞周期蛋白依赖性激酶,观察不同谱系肿瘤之间的基因表达谱。
BMC Med Genomics. 2022 Mar 8;15(1):52. doi: 10.1186/s12920-022-01206-y.
10
Prediction of biomarkers and therapeutic combinations for anti-PD-1 immunotherapy using the global gene network association.利用全球基因网络关联预测抗 PD-1 免疫治疗的生物标志物和治疗组合。
Nat Commun. 2022 Jan 10;13(1):42. doi: 10.1038/s41467-021-27651-4.